Rizzo Giovanni, Zanigni Stefano, De Blasi Roberto, Grasso Daniela, Martino Davide, Savica Rodolfo, Logroscino Giancarlo
IRCCS Istituto delle Scienze Neurologiche, Bellaria Hospital, Bologna, Italy; Neurology Unit, Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.
Functional MR Unit, Policlinico S.Orsola-Malpighi, Bologna, Italy; Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.
Parkinsons Dis. 2016;2016:2983638. doi: 10.1155/2016/2983638. Epub 2016 Sep 28.
Brain magnetic resonance (MR) represents a useful and feasible tool for the differential diagnosis of Parkinson's disease. Conventional MR may reveal secondary forms of parkinsonism and may show peculiar brain alterations of atypical parkinsonian syndromes. Furthermore, advanced MR techniques, such as morphometric-volumetric analyses, diffusion-weighted imaging, diffusion tensor imaging, tractography, proton MR spectroscopy, and iron-content sensitive imaging, have been used to obtain quantitative parameters useful to increase the diagnostic accuracy. Currently, many MR studies have provided both qualitative and quantitative findings, reflecting the underlying neuropathological pattern of the different degenerative parkinsonian syndromes. Although the variability in the methods and results across the studies limits the conclusion about which technique is the best, specific radiologic phenotypes may be identified. Qualitative/quantitative MR changes in the substantia nigra do not discriminate between different parkinsonisms. In the absence of extranigral abnormalities, the diagnosis of PD is more probable, whereas basal ganglia changes (mainly in the putamen) suggest the diagnosis of an atypical parkinsonian syndrome. In this context, changes in pons, middle cerebellar peduncles, and cerebellum suggest the diagnosis of MSA, in midbrain and superior cerebellar peduncles the diagnosis of PSP, and in whole cerebral hemispheres (mainly in frontoparietal cortex with asymmetric distribution) the diagnosis of Corticobasal Syndrome.
脑磁共振成像(MR)是帕金森病鉴别诊断中一种有用且可行的工具。传统MR可能揭示帕金森综合征的继发形式,并可能显示非典型帕金森综合征特有的脑部改变。此外,先进的MR技术,如实形态计量体积分析、扩散加权成像、扩散张量成像、纤维束成像、质子磁共振波谱和铁含量敏感成像,已被用于获取有助于提高诊断准确性的定量参数。目前,许多MR研究提供了定性和定量结果,反映了不同退行性帕金森综合征潜在的神经病理模式。尽管各研究在方法和结果上存在差异,限制了关于哪种技术最佳的结论,但仍可识别出特定的放射学表型。黑质的定性/定量MR改变无法区分不同的帕金森综合征。在没有黑质外异常的情况下,帕金森病的诊断可能性更大,而基底节改变(主要在壳核)提示非典型帕金森综合征的诊断。在这种情况下,脑桥、小脑中脚和小脑的改变提示多系统萎缩的诊断,中脑和上小脑脚的改变提示进行性核上性麻痹的诊断,全脑半球(主要在额顶叶皮质,分布不对称)的改变提示皮质基底节综合征的诊断。